(Q42276206)

19 October 2017

title

Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium (English)

1 reference

19 October 2017

Hong Guo-Parke

1

1 reference

19 October 2017

Paul Canning

2

1 reference

19 October 2017

Isobel Douglas

3

1 reference

19 October 2017

Rémi Villenave

4

1 reference

19 October 2017

Liam G Heaney

5

1 reference

19 October 2017

Peter V Coyle

6

1 reference

19 October 2017

Jeremy D Lyons

7

1 reference

19 October 2017

Michael D Shields

8

1 reference

19 October 2017

Ultan F Power

9

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

American Journal of Respiratory and Critical Care Medicine

19 October 2017

published in

1 reference

19 October 2017

volume

188

1 reference

19 October 2017

issue

7

1 reference

19 October 2017

page(s)

842-851

1 reference

Immunopathogenesis of respiratory syncytial virus bronchiolitis

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

The pathogenesis of respiratory syncytial virus disease in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Respiratory syncytial virus--viral biology and the host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Recovery of the ciliated epithelium following acute bronchiolitis in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Culture and comparison of human bronchial and nasal epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

A 3-D well-differentiated model of pediatric bronchial epithelium demonstrates unstimulated morphological differences between asthmatic and nonasthmatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Cytokine amplification by respiratory syncytial virus infection in human nasal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

The histopathology of fatal untreated human respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Leucocyte populations in respiratory syncytial virus-induced bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

The effect of respiratory synctial virus on chemokine release by differentiated airway epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Viral load drives disease in humans experimentally infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201304-0750OC

10.1164/RCCM.201304-0750OC

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference